朱忠远 bought 30,000 shares of DUALITYBIO-B (09606) on the SEHK open market at an average of HKD 105.3923 per share on November 4, 2026, involving about HKD 3.16 million — an on-exchange active trade matched on the SEHK open market and therefore a direct secondary-market dealing.
Prior to the acquisition, 朱忠远's long position in DUALITYBIO-B was 16.14 million shares, representing 17.56%; following the acquisition, the holding changed to 16.17 million shares, with the long position ratio rising to 17.59%.
Source: Hong Kong Exchanges and Clearing Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments